Breaking News, Financial News

Financial Report: PPD 1Q

Development segment revenue was $335.4 million (-7%). Discovery sciences segment revenue was $5.7 million (-64%).

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

PPD 1Q 1Q Revenues: $364.9 million (-7%) 1Q Earnings:$44.6 million (+11%) Comments: Development segment revenue was $335.4 million (-7%). Discovery sciences segment revenue was $5.7 million (-64%), which included two milestone payments from Janssen-Cilag totaling $5.0 million. New business authorizations for the quarter totaled $579.7 million. Contract cancellations and adjustments for the quarter were $214.6 million, including a $76.9 million cancellation from a large biotech client fo...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters